Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
19.88
+2.35 (13.41%)
At close: Jul 2, 2025, 4:00 PM
20.81
+0.93 (4.68%)
Pre-market: Jul 3, 2025, 6:18 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.94 billion as of July 3, 2025. Its market cap has decreased by -1.25% in one year.
Market Cap
1.94B
Enterprise Value
876.20M
1-Year Change
-1.25%
Ranking
Category
Stock Price
$19.88
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.94B, an increase of 490.91%. That is a compound annual growth rate of 38.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 1.94B | -1.82% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.07B |
| Johnson & Johnson | 375.15B |
| AbbVie | 337.81B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 282.16B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 234.41B |
| AstraZeneca | 219.33B |